PharmAbcine Inc - Product Pipeline Review - 2016

Published: Dec, 2016 | Pages: 38 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

PharmAbcine Inc - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'PharmAbcine Inc - Product Pipeline Review - 2016', provides an overview of the PharmAbcine Inc's pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by PharmAbcine Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of PharmAbcine Inc
- The report provides overview of PharmAbcine Inc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses PharmAbcine Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features PharmAbcine Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate PharmAbcine Inc's strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for PharmAbcine Inc
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding PharmAbcine Inc's pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
PharmAbcine Inc Snapshot 6
PharmAbcine Inc Overview 6
Key Facts 6
PharmAbcine Inc - Research and Development Overview 7
Key Therapeutic Areas 7
PharmAbcine Inc - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
PharmAbcine Inc - Pipeline Products Glance 12
PharmAbcine Inc - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
PharmAbcine Inc - Drug Profiles 14
Monoclonal Antibody to Antagonize c-Met for Oncology and Inflammatory Disorders - Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
Monoclonal Antibody to Antagonize EGFR for Oncology and Inflammatory Disorders - Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
Monoclonal Antibody to Antagonize HER2 for Oncology and Inflammatory Disorders - Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
Monoclonal Antibody to Antagonize IGFR-1 for Oncology and Inflammatory Disorders - Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
Monoclonal Antibody to Antagonize VEGFR-1 for Oncology and Inflammatory Disorders - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
Monoclonal Antibody to Antagonize VEGFR-3 for Oncology and Inflammatory Disorders - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
Monoclonal Antibody to Inhibit DLL4 for Oncology and Inflammatory Disorders - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Monoclonal Antibody to Inhibit EPCAM for Oncology and Inflammatory Disorders - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
Monoclonal Antibody to Target CD-20 for Oncology and Inflammatory Disorders - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
PMC-001 - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
PMC-002 - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
PMC-201 - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
TTAC-0001 - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
PharmAbcine Inc - Pipeline Analysis 29
PharmAbcine Inc - Pipeline Products by Target 29
PharmAbcine Inc - Pipeline Products by Route of Administration 31
PharmAbcine Inc - Pipeline Products by Molecule Type 32
PharmAbcine Inc - Pipeline Products by Mechanism of Action 33
PharmAbcine Inc - Dormant Projects 35
PharmAbcine Inc - Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 37
Disclaimer 38

List of Tables

PharmAbcine Inc, Key Facts 6
PharmAbcine Inc - Pipeline by Indication, 2016 8
PharmAbcine Inc - Pipeline by Stage of Development, 2016 10
PharmAbcine Inc - Monotherapy Products in Pipeline, 2016 11
PharmAbcine Inc - Preclinical, 2016 12
PharmAbcine Inc - Discovery, 2016 13
PharmAbcine Inc - Pipeline by Target, 2016 30
PharmAbcine Inc - Pipeline by Route of Administration, 2016 31
PharmAbcine Inc - Pipeline by Molecule Type, 2016 32
PharmAbcine Inc - Pipeline Products by Mechanism of Action, 2016 34
PharmAbcine Inc - Dormant Developmental Projects,2016 35
PharmAbcine Inc, Other Locations 36